Form 4/A for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-01-03 00:00:00 ET · period of report 2023-09-07 · accession 0001801170-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-01-03 | 2023-09-07 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | A - Grant | $0.00 | +652.6K | 2.03M | +47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-09-07 | A | A | 652,566 | $0.00 | 2,033,451 | D | — | — | (F1) This Form 4/A is being filed solely to correct the number of restricted stock units (RSUs) received upon determination of the level of performance, as described in Footnote 2 below. (F2) Represents RSUs, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned RSUs vested and were settled on September 7, 2023, and one-third of the number of earned RSUs will vest on each of June 30, 2024, and June 30, 2025, subject to the Reporting Person's continued employment through each vesting date. |